Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Post by bealerton Jun 18, 2023 5:24pm
188 Views
Post# 35502658

Thank you all for your recent posts

Thank you all for your recent postsEveryone has valid concerns about SBM and I agree that the 2 biggest problems are #1: CEO,
#2: The lame PR people that we waste tens of thousands of $$$ on for repeating basically nothing.
The press releases are obviously not exciting those we need to reach as the shitty share price shows. This is a disgusting price of 12.5 cents for where we are supposedly at in the science.  We are gonna fritter away another opportunity as the management again try to 'get it right'.  Obviously they haven't gotten it right yet and that's why we are down this low.

How many times do they expect us to be made fools of???

I think that the CFO has little sense of value for how they waste money and he should be stepping up to the plate just like the CEO.  

How many time are we going to get diluted?  We have over 1/4th billiion shares issued already.  That's a lot, folks.

Come on Sirona team. Grow up already and get a sense of urgency.

Hopefully you can somehow come up with a great deal out of the bio conference and get this fired up to new highs.

BeAlert
<< Previous
Bullboard Posts
Next >>